The purpose of the proposed new study is to conduct a precursor lesion genomics study to determine DNA alterations in premalignant esophageal lesions. Our goals for this new study are (i) to understand the molecular underpinnings of premalignant esophageal lesions and (ii) to test molecular lesions found in high grade premalignant lesions as biomarkers in the early detection screening program.